The Food and Drug Administration has announced that the Office of New Animal Drug Evaluation within the Center for Veterinary Medicine will reorganize the into two separate groups.  These will comprise the Office of New Animal Product Evaluation and the Office of Generic Animal Drugs.  The reorganization is intended to expedite review and approval of drugs and is consistent with changes at the Food and Drug Administration to improve efficiency and service.